[go: up one dir, main page]

MX2007006365A - Mejorador del efecto de adrenocorticoide, que comprende goma arabiga. - Google Patents

Mejorador del efecto de adrenocorticoide, que comprende goma arabiga.

Info

Publication number
MX2007006365A
MX2007006365A MX2007006365A MX2007006365A MX2007006365A MX 2007006365 A MX2007006365 A MX 2007006365A MX 2007006365 A MX2007006365 A MX 2007006365A MX 2007006365 A MX2007006365 A MX 2007006365A MX 2007006365 A MX2007006365 A MX 2007006365A
Authority
MX
Mexico
Prior art keywords
adrenocorticoid
effect
enhancer
gum arabic
nephritis
Prior art date
Application number
MX2007006365A
Other languages
English (en)
Inventor
Hideaki Matsuda
Michinori Kubo
Original Assignee
Veritron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veritron Ltd filed Critical Veritron Ltd
Publication of MX2007006365A publication Critical patent/MX2007006365A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invencion proporciona un mejorador del efecto de adrenocorticoide en nefritis sin el realce de los efectos secundarios indeseable de dicho adrenocorticoide, que comprende la goma soluble en agua obtenida de la familia y/o derivacion de las especies Acacia, por ejemplo goma arabiga; la combinacion del adrenocorticoide y de la goma soluble en agua mejora el efecto de dicho adrenocorticoide en la nefritis sin realzar los efectos secundarios indeseables del agente hormonal.
MX2007006365A 2004-11-30 2005-11-29 Mejorador del efecto de adrenocorticoide, que comprende goma arabiga. MX2007006365A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004346673 2004-11-30
PCT/JP2005/022267 WO2006059764A2 (en) 2004-11-30 2005-11-29 Enhancer of the effect of adrenocorticoid, comprising gum arabic

Publications (1)

Publication Number Publication Date
MX2007006365A true MX2007006365A (es) 2007-06-20

Family

ID=36250826

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007006365A MX2007006365A (es) 2004-11-30 2005-11-29 Mejorador del efecto de adrenocorticoide, que comprende goma arabiga.

Country Status (17)

Country Link
US (1) US20090060944A1 (es)
EP (1) EP1817040A2 (es)
JP (1) JP2008521791A (es)
KR (1) KR20070084588A (es)
CN (1) CN101232889A (es)
AP (1) AP2007004022A0 (es)
AU (1) AU2005310453A1 (es)
BR (1) BRPI0518712A2 (es)
CA (1) CA2584136A1 (es)
IL (1) IL182951A0 (es)
MA (1) MA29105B1 (es)
MX (1) MX2007006365A (es)
NO (1) NO20073379L (es)
RU (1) RU2007124549A (es)
TW (1) TW200631590A (es)
WO (1) WO2006059764A2 (es)
ZA (1) ZA200704404B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200803883A (en) * 2005-09-22 2008-01-16 Veritron Ltd Enhancer of cholinesterase activity
DE102006061517A1 (de) * 2006-12-18 2008-06-19 Eberhard-Karls-Universität Tübingen Universitätsklinikum Angioinhibin
DE102007039310A1 (de) * 2007-08-13 2009-02-19 Eberhard-Karls-Universität Tübingen Universitätsklinikum Zusammensetzung zur Prophylaxe und Behandlung von Osteoporose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB841998A (en) * 1956-11-28 1960-07-20 Merck & Co Inc Steroid compounds
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides

Also Published As

Publication number Publication date
EP1817040A2 (en) 2007-08-15
AU2005310453A1 (en) 2006-06-08
WO2006059764A3 (en) 2007-04-19
TW200631590A (en) 2006-09-16
BRPI0518712A2 (pt) 2008-12-02
CA2584136A1 (en) 2006-06-08
US20090060944A1 (en) 2009-03-05
CN101232889A (zh) 2008-07-30
RU2007124549A (ru) 2009-01-10
KR20070084588A (ko) 2007-08-24
MA29105B1 (fr) 2007-12-03
ZA200704404B (en) 2008-08-27
IL182951A0 (en) 2007-09-20
JP2008521791A (ja) 2008-06-26
NO20073379L (no) 2007-06-29
AP2007004022A0 (en) 2007-06-30
WO2006059764A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
NZ608860A (en) Methods and reagents for treatment and diagnosis of age-related macular degeneration
WO2007092622A3 (en) Compositions and methods for treating bone
TW200736611A (en) Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
MX2008011874A (es) Composiciones estabilizadas de polipeptidos.
NO20076401L (no) Diarylhydantoinforbindelser
TW200738270A (en) Method of treating depression using a TNFα antibody
WO2005079756A3 (en) Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
TW200608973A (en) Rapamycin polymorph Ⅱ and uses thereof
WO2006066024A8 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
ATE524487T1 (de) Tau peptidmimetikum zur behandlung von neurodegenerativen erkrankungen
TNSN07453A1 (en) Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
WO2005110479A3 (en) Treatments for pancreatic cancer
EA200801180A1 (ru) Селективные пептидные агонисты рецептора vpac2
WO2006019982A3 (en) Pin1-modulating compounds and methods of use thereof
WO2007025303A3 (en) Non-steroidal antiandrogens
WO2004024082A3 (en) Highly specific modulators of gtpases for target validation
TW200631590A (en) Enhancer of the effect of adrenocorticoid, comprising gum arabic
WO2007000764A3 (en) Compositions and methods for enhancement of sexual function
ATE542535T1 (de) Verwendung von azapaullonen zur vorbeugung und behandlung pankreatischer autoimmunkrankheiten
TW200602062A (en) Improved formulations of 6-mercaptopurine
WO2005094761A8 (en) Hair treatment compositions comprising a disaccharide, a di-acid and a source of ammonium ions
WO2006015191A3 (en) Multicyclic lonidamine analogs
AU2003285485A1 (en) 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
WO2006091965A3 (en) Nod1 as an anti-tumor agent

Legal Events

Date Code Title Description
FA Abandonment or withdrawal